1. Home
  2. ATNM vs VHC Comparison

ATNM vs VHC Comparison

Compare ATNM & VHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Actinium Pharmaceuticals Inc. (Delaware)

ATNM

Actinium Pharmaceuticals Inc. (Delaware)

HOLD

Current Price

$1.42

Market Cap

50.2M

Sector

Health Care

ML Signal

HOLD

Logo VirnetX Holding Corp

VHC

VirnetX Holding Corp

HOLD

Current Price

$19.98

Market Cap

70.7M

Sector

Miscellaneous

ML Signal

HOLD

Company Overview

Basic Information
Metric
ATNM
VHC
Founded
2000
2005
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Multi-Sector Companies
Sector
Health Care
Miscellaneous
Exchange
Nasdaq
Nasdaq
Market Cap
50.2M
70.7M
IPO Year
N/A
1999

Fundamental Metrics

Financial Performance
Metric
ATNM
VHC
Price
$1.42
$19.98
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$4.00
N/A
AVG Volume (30 Days)
206.2K
14.3K
Earning Date
11-14-2025
11-14-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$90,000.00
$106,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
11.11
2020.00
52 Week Low
$1.03
$3.68
52 Week High
$2.41
$29.00

Technical Indicators

Market Signals
Indicator
ATNM
VHC
Relative Strength Index (RSI) 54.26 41.33
Support Level $1.33 $19.20
Resistance Level $1.48 $23.70
Average True Range (ATR) 0.11 1.88
MACD 0.02 -0.60
Stochastic Oscillator 58.90 12.73

Price Performance

Historical Comparison
ATNM
VHC

About ATNM Actinium Pharmaceuticals Inc. (Delaware)

Actinium Pharmaceuticals Inc is a biopharmaceutical company engaged in the development of radiotherapies for patients with cancers lacking effective treatment options. The company's proprietary technology platform utilizes monoclonal antibodies to deliver radioisotopes directly to cells of interest to kill those cells safely and effectively. Its product candidates are Iomab-B, an antibody-drug construct containing iodine 131 (I-131), used for hematopoietic stem cells transplantation in various indications, and Actimab-A, an antibody-drug construct containing actinium 225 (Ac-225), currently in human clinical trials for acute myeloid leukemia.

About VHC VirnetX Holding Corp

VirnetX Holding Corp is engaged in the business of commercializing a portfolio of patents. It is an Internet security software and technology company with patented technology for secure communications. The company's software and technology solutions, including its Secure Domain Name Registry and Technology, VirnetX One, War Room, VirnetX Matrix, and GABRIEL Connection Technology, are designed to be device and location-independent, and enable a secure real-time communication environment for all types of enterprise applications, services and critical infrastructures.

Share on Social Networks: